Abstract
Estonia, a transition country being 'catching-up economy', is complementing its capacity for technology absorption with potential for diffusion and commercialisation of technology. The aim of the paper is to study key issues related to university-industry knowledge transfer within the Estonian biotech sector. Empirical research of the SME sector was carried out in two sample groups: the first were Estonian research based biotech companies with independent strategies and the second were subsidiaries of foreign companies. The gross funding structure proportions of basic research, applied research, and product or service development in the Estonian biotechnology public and private sectors together were calculated as 11 : 5 : 1, which demonstrates the strong imbalance of the sectoral innovation processes. Balancing R&D is seen as an iterative process.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Entrepreneurship and Innovation Management
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
